Rocket Pharmaceuticals, Inc. (RCKT) has a market capitalization of $421.25M and trades at $3.88. The 52-week range is 2.19-8.26.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1.9, Earnings Per Share (EPS) of $-2.01.
The stock has a beta of 0.57, operates in the Healthcare sector.
